Insider Buying: AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Acquires $56,100.00 in Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett acquired 30,000 shares of AirSculpt Technologies stock in a transaction that occurred on Wednesday, March 4th. The stock was purchased at an average price of $1.87 per share, with a total value of $56,100.00. Following the transaction, the insider owned 6,352,611 shares of the company’s stock, valued at $11,879,382.57. This trade represents a 0.47% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Tuesday, March 3rd, Jorey Chernett acquired 80,000 shares of AirSculpt Technologies stock. The stock was acquired at an average cost of $1.71 per share, for a total transaction of $136,800.00.

AirSculpt Technologies Stock Performance

NASDAQ AIRS opened at $2.09 on Friday. The stock has a market capitalization of $130.50 million, a price-to-earnings ratio of -6.97 and a beta of 2.75. The business’s 50 day moving average is $2.20 and its two-hundred day moving average is $4.86. AirSculpt Technologies, Inc. has a 12-month low of $1.51 and a 12-month high of $12.00. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.63.

Analyst Ratings Changes

Several research firms have issued reports on AIRS. Weiss Ratings reiterated a “sell (d-)” rating on shares of AirSculpt Technologies in a research report on Monday, December 29th. Leerink Partners restated a “market perform” rating and set a $6.00 target price on shares of AirSculpt Technologies in a research report on Tuesday, November 11th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $6.00.

Institutional Investors Weigh In On AirSculpt Technologies

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Larson Financial Group LLC boosted its stake in shares of AirSculpt Technologies by 20.4% during the 3rd quarter. Larson Financial Group LLC now owns 15,137 shares of the company’s stock worth $121,000 after acquiring an additional 2,561 shares in the last quarter. Wexford Capital LP increased its stake in AirSculpt Technologies by 2.6% in the 3rd quarter. Wexford Capital LP now owns 102,614 shares of the company’s stock valued at $823,000 after purchasing an additional 2,614 shares in the last quarter. Rhumbline Advisers increased its stake in AirSculpt Technologies by 16.1% in the 3rd quarter. Rhumbline Advisers now owns 20,782 shares of the company’s stock valued at $167,000 after purchasing an additional 2,876 shares in the last quarter. Creative Planning raised its holdings in AirSculpt Technologies by 32.2% during the second quarter. Creative Planning now owns 13,225 shares of the company’s stock worth $64,000 after purchasing an additional 3,224 shares during the last quarter. Finally, BNP Paribas Financial Markets raised its holdings in AirSculpt Technologies by 239.5% during the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock worth $48,000 after purchasing an additional 4,199 shares during the last quarter. 91.54% of the stock is currently owned by institutional investors and hedge funds.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.